| Prev Close: | 3.90 |
|---|---|
| Open: | 3.95 |
| Bid: | N/A |
| Ask: | 6.87 x 200 |
| 1y Target Est: | 9.00 |
| Beta: | 0.99 |
| Next Earnings Date: | 3-Jun-13 |
| Day's Range: | 3.85 - 4.42 |
|---|---|
| 52wk Range: | 2.66 - 7.00 |
| Volume: | 121,945 |
| Avg Vol (3m): | 136,941 |
| Market Cap: | 22.53M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.26 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Bypassing Biotechs and Focusing on the Overlooked Medical Device Space: An Expert Portfolio Manager Discusses His Contrarian Approach to InvestingWall Street Transcript(Fri, May 17)
- Short On Oculus: Wound Care Company Has Left Dirty Scarsat Seeking Alpha(Tue, May 7)
- Oculus Innovative Sciences Announces New Regulatory Approvals for Microcyn(R)-Based Antiseptic Products in Panama and El SalvadorGlobeNewswire(Wed, May 1)
- Oculus Innovative Sciences Announces New Regulatory Approvals and Target Launch Dates for Three New Microcyn(R)-Based Products in Middle East CountriesGlobeNewswire(Wed, Apr 24)
- Align's Earnings Beat Ests, Revs GrowZacks(Fri, Apr 19)
- Wound Care Market: The Promise Of Healingat Seeking Alpha(Sat, Apr 13)
- Oculus Innovative Sciences to Rollout Five New Microcyn(R) Technology-Based Products in Singapore and MalaysiaGlobeNewswire(Wed, Apr 10)
- Small Pharma Watch List: Week Of April 8, 2013at Seeking Alpha(Mon, Apr 8)
- Oculus issued three new international patents for Microcyn technologytheflyonthewall.com(Thu, Apr 4)
- Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of Three New International Patents for Microcyn(R) TechnologyGlobeNewswire(Thu, Apr 4)
- Oculus And NovaBay: 100% Upside Potentialat Seeking Alpha(Mon, Apr 1)
- David & Goliath: Small Biotechs Wage a Big Fight Against the Superbugat Minyanville(Mon, Apr 1)
- Oculus Innovative Sciences Announces Reverse Split of Common StockGlobeNewswire(Thu, Mar 28)
- Oculus Innovative Sciences Expands Regulatory Claims for Microcyn-Based Advanced Wound Management Products in EuropeGlobeNewswire(Tue, Mar 26)
- OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to ArticleEDGAR Online(Fri, Mar 22)
Press Releases
- Oculus Innovative Sciences Announces New Regulatory Approvals for Microcyn(R)-Based Antiseptic Products in Panama and El SalvadorGlobeNewswire(Wed, May 1)
- Oculus Innovative Sciences Announces New Regulatory Approvals and Target Launch Dates for Three New Microcyn(R)-Based Products in Middle East CountriesGlobeNewswire(Wed, Apr 24)
- Oculus Innovative Sciences to Rollout Five New Microcyn(R) Technology-Based Products in Singapore and MalaysiaGlobeNewswire(Wed, Apr 10)
Reports
- ValuEngine Industry Report for Medical/dental-suppliesValuEngine, Inc.(May 17)
- ValuEngine Detailed Valuation Report for OCLSValuEngine, Inc.(May 16)
- Oculus Innovative SciencesS&P Capital IQ Quantitative Report(May 11)